Gyroscope Therapeutics is a clinical-stage gene therapy company focused on developing therapies and treating diseases of the eye. The company's main goal is to explore the convergence of advancements made in the understanding of the complement system's impact on eye disease, the genetic basis of Age-related Macular Degeneration (AMD), and gene therapy as a mode of treatment delivery. Their lead in...